Jinshi Pharmaceutical (300434.SZ) announced its first-half results, with net profit of 954.742 million yuan to mother, an increase of 45.22% over the previous year

According to the Zhitong Finance App, Jinshi Asia Pharmaceutical (300434.SZ) released its 2026 semi-annual report. During the reporting period, the company achieved revenue of 491 million yuan, a year-on-year decrease of 0.22%. Achieved net profit of 954.742 million yuan attributable to shareholders of listed companies, an increase of 45.22% over the previous year. Achieved net profit of 862,165 million yuan after deducting non-recurring profit and loss attributable to shareholders of listed companies, an increase of 54.72% over the previous year.